Bluejay Diagnostics(BJDX) - 2022 Q4 - Annual Report

For the Fiscal Year Ended December 31, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41031 Bluejay Diagnostics, Inc. (Exact Name of Registrant as Specified in Its Charter) TABLE OF CONTENTS | --- | --- | --- | |------------|----------------------------------------------------------------------------------------------|-------| | | | Page | | CAUTIONARY | NOTE REGARDING FORWARD-LOOKING STATEMENTS | ii | | SUMMARY | OF RISK FACTOR ...